1.Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Ga Young PARK ; Chung Hoon YU ; Jun Seop KIM ; Yun Jeong KANG ; Owen KWON ; Ji Young CHOI ; Jang Hee CHO ; Chan Duck KIM ; Yong Lim KIM ; Sun Hee PARK
The Korean Journal of Internal Medicine 2015;30(3):345-353
BACKGROUND/AIMS: Neutrophil gelatinase-associated lipocalin (NGAL) is a well-known biomarker of acute kidney injury. We evaluated the value of plasma NGAL (pNGAL) as an independent predictor of prognosis in immunoglobulin A nephropathy (IgAN). METHODS: In total, 91 patients with biopsy-proven IgAN at a single center were evaluated. pNGAL was measured using a commercial enzyme-linked immunosorbent assay kit (R&D Systems). Adverse renal outcome was defined as chronic kidney disease (CKD) stage 3 or above at the last follow-up. Pearson correlation coefficient and Cox regression were used for analyses. RESULTS: The mean age of all patients (male:female, 48:43) was 35 years (range, 18 to 77). pNGAL ranged between 21.68 and 446.40 ng/mL (median, 123.97) and showed a correlation with age (r = 0.332, p = 0.001), creatinine (r = 0.336, p = 0.001), estimated glomerular filtration rate (r = -0.397, p < 0.001), uric acid (r = 0.289, p = 0.006), and the protein-to-creatinine ratio (r = 0.288, p = 0.006). During a mean follow-up period of 37.6 months, 11 patients (12.1%) had CKD stage 3 or above. In a multivariate Cox regression model, hypertension (hazard ratio [HR], 8.779; 95% confidence interval [CI], 1.526 to 50.496; p = 0.015), proteinuria > 1 g/day (HR, 5.184; 95% CI, 1.124 to 23.921; p = 0.035), and pNGAL (HR, 1.012; 95% CI, 1.003 to 1.022; p = 0.013) were independent predictors associated with adverse renal outcome. CONCLUSIONS: pNGAL showed strong correlations with other clinical prognostic factors and was also an independent predictor of adverse renal outcome. We suggest pNGAL as a potential predictor for prognosis in IgAN, while further studies are needed to confirm the clinical value.
Acute-Phase Proteins
;
Adolescent
;
Adult
;
Aged
;
Biomarkers/blood
;
Biopsy
;
Chi-Square Distribution
;
Creatinine/blood
;
Disease Progression
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Glomerular Filtration Rate
;
Glomerulonephritis, IGA/*blood/complications/pathology/physiopathology
;
Humans
;
Kidney/*metabolism/pathology/physiopathology
;
Linear Models
;
Lipocalins/*blood
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Predictive Value of Tests
;
Prognosis
;
Proportional Hazards Models
;
Proto-Oncogene Proteins/*blood
;
Renal Insufficiency, Chronic/blood/etiology
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Time Factors
;
Young Adult
2.Clinical characteristics of children with an initial onset of IgA nephropathy with nephrotic syndrome.
Liang ZHANG ; Zhi-Hui LI ; Yan YIN ; Cui-Rong DUAN ; Mai XUN ; Tian-Hui WU ; Yi ZHANG ; Yun-Feng DING
Chinese Journal of Contemporary Pediatrics 2015;17(8):786-791
OBJECTIVETo study the clinical characteristics of children with an initial onset of IgA nephropathy with nephrotic syndrome and compare them with children with primary nephrotic syndrome, in order to provide a theoretical basis for the differential diagnosis of the two diseases.
METHODSFifty children diagnosed with an initial onset of IgA nephropathy with nephrotic syndrome were included in this study. Seventy-two children diagnosed with an initial onset of primary nephrotic syndrome served as the control group. The clinical and laboratory examination characteristics were compared between the two groups.
RESULTSThe IgA nephropathy group had significantly higher incidence rates of gross haematuria, microscopic haematuria, hypertension, acute kidney injury, low serum high-density lipoprotein cholesterol, anemia, low serum complement C4, steroid resistance, and nephritis-type nephrotic syndrome and a significantly lower incidence of elevated serum IgE compared with the control group (P<0.05). There were significant differences in serum creatinine, serum uric acid, serum total cholesterol, serum high-density lipoprotein cholesterol, serum IgE, serum complement C4, and hemoglobin levels between the IgA nephropathy and the control groups (P<0.05). The thresholds of serum IgE (<131.2 IU/mL) and high-density lipoprotein cholesterol (<1.35 mmol/L) were reference parameters in the differential diagnosis of IgA nephropathy with nephrotic syndrome and primary nephrotic syndrome.
CONCLUSIONSChildren with IgA nephropathy presenting nephrotic syndrome manifest mainly as nephritis type and steroid-resistant type in the clinical classification. Cinical manifestations accompanied by serum levels of high-density lipoprotein cholesterol and IgE are helpful for differential diagnosis of IgA nephropathy presenting nephrotic syndrome and primary nephrotic syndrome.
Adolescent ; Child ; Child, Preschool ; Cholesterol, HDL ; blood ; Complement C4 ; analysis ; Female ; Glomerulonephritis, IGA ; blood ; complications ; Hematuria ; etiology ; Humans ; Immunoglobulin E ; blood ; Male ; Nephrotic Syndrome ; blood ; complications
3.Fabry disease previously diagnosed as Henoch-Schonlein purpura.
Ji Hyeong KIM ; Dong Hoon HAN ; Moo Yong PARK ; Soo Jeong CHOI ; Jin Kuk KIM ; Seung Duk HWANG ; So Young JIN
The Korean Journal of Internal Medicine 2015;30(6):925-927
No abstract available.
Biopsy
;
DNA Mutational Analysis
;
*Diagnostic Errors
;
Enzyme Replacement Therapy
;
Fabry Disease/complications/*diagnosis/enzymology/genetics
;
Genetic Predisposition to Disease
;
Glomerulonephritis, IGA/diagnosis/etiology
;
Humans
;
Male
;
Middle Aged
;
Mutation
;
Phenotype
;
Predictive Value of Tests
;
Purpura, Schoenlein-Henoch/*diagnosis
;
alpha-Galactosidase/genetics/therapeutic use
5.Potential association of hyperhomocysteinemia with the progression of IgA nephropathy: a retrospective study.
Shuwei DUAN ; Shuwen LIU ; Xuefeng SUN ; Ying ZHENG ; Linchang LIU ; Feixiang YAO ; Jie WU
Chinese Medical Journal 2014;127(10):1849-1852
BACKGROUNDThe high blood homocysteine (Hcy) levels found in patients with hyperhomocysteinemia (HHcy) have been implicated in an increased risk of cardiovascular disease morbidity and mortality in end-stage renal disease (ESRD). This study investigated the association of HHcy with progression of IgA nephropathy.
METHODSWe analyzed 108 participants newly diagnosed with IgA nephropathy between August 2005 and August 2007 in the Department of Nephrology, Chinese People's Liberation Army General Hospital. The association between clinicopathological factors and the Hcy levels were analyzed by Logistic regression and those with ESRD risk were analyzed by Cox regression.
RESULTSPatients were aged (35.71 ± 10.73) years and included 45.71% women and 12.04% patients with HHcy. In multivariate Logistic regression analysis, HHcy was associated with arterial lesions (OR 2.60; 95% CI 1.55 ± 4.34; P < 0.001) even when age, body mass index, estimated glomerular filtration rate, mean arterial pressure, and initial proteinuria were taken into account. Mean follow-up was (67.37 ± 16.21) months. HHcy was also associated with worse ESRD-free survival (HR 4.71; 95% CI 1.45 to 15.31; P = 0.010).
CONCLUSIONHHcy is associated with the risk of intrarenal arterial lesions and may be useful for estimating the prognosis of IgA nephropathy.
Adult ; Body Mass Index ; Female ; Glomerular Filtration Rate ; physiology ; Glomerulonephritis, IGA ; etiology ; physiopathology ; Humans ; Hyperhomocysteinemia ; complications ; physiopathology ; Logistic Models ; Male ; Middle Aged ; Retrospective Studies
6.Beta-Thalassemia Minor Is Associated with IgA Nephropathy.
Jung Hyun KANG ; Bo Rha PARK ; Kyung Soo KIM ; Do Yeun KIM ; Hee Jin HUH ; Seok Lae CHAE ; Sung Joon SHIN
Annals of Laboratory Medicine 2013;33(2):153-155
No abstract available.
Aged
;
Anemia/diagnosis
;
Bone Marrow Cells/pathology
;
Chromosomes, Human, Pair 11
;
Electrophoresis
;
Glomerulonephritis, IGA/complications/*diagnosis
;
Hematuria/pathology
;
Hemoglobin A/analysis
;
Heterozygote
;
Humans
;
Male
;
Renal Insufficiency/diagnosis
;
beta-Globins/genetics
;
beta-Thalassemia/*diagnosis/etiology
7.Progression in the mechanism of the Cosmc in IgA nephropathy.
Chinese Journal of Pediatrics 2013;51(7):549-551
Azacitidine
;
pharmacology
;
Base Sequence
;
Chromosomes, Human, X
;
genetics
;
DNA Methylation
;
drug effects
;
DNA Mutational Analysis
;
Galactosyltransferases
;
metabolism
;
Gene Expression Regulation
;
drug effects
;
Glomerulonephritis, IGA
;
etiology
;
genetics
;
metabolism
;
Glycosylation
;
Humans
;
Immunoglobulin A
;
metabolism
;
Lipopolysaccharides
;
pharmacology
;
Lymphocytes
;
metabolism
;
Molecular Chaperones
;
genetics
;
metabolism
;
Mutation
;
Polymorphism, Single Nucleotide
8.Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes.
Ja Min BYUN ; Cheol Hyun LEE ; Sul Ra LEE ; Ju Young MOON ; Sang Ho LEE ; Tae Won LEE ; Chun Gyoo IHM ; Kyung Hwan JEONG
The Korean Journal of Internal Medicine 2013;28(5):565-572
BACKGROUND/AIMS: In several recent studies, renal biopsies in patients with type 2 diabetes and renal disease have revealed a heterogeneous group of disease entities. Our aim was to study the prognosis and clinical course of nondiabetic renal disease (NDRD) and to determine risk factors for NDRD in patients with type 2 diabetes. METHODS: Renal biopsy reports of 110 patients with type 2 diabetes who were seen at Kyung Hee University Medical Center and Kyung Hee University Hospital at Gangdong, Seoul, Korea between January 2000 and December 2011 were retrospectively analyzed. RESULTS: Of 110 patients with type 2 diabetes, 41 (37.3%) had diabetic nephropathy (DN), 59 (53.6%) had NDRD, and 10 (9.1%) had NDRD superimposed on DN. Immunoglobulin A nephropathy (43.5%) was the most common NDRD. Patients with NDRD had a shorter duration of diabetes, lower frequency of diabetic retinopathy, and better renal outcomes, which might have resulted from the use of aggressive disease-specific treatments such as steroids and immunosuppressants in patients with NDRD. CONCLUSIONS: Compared with DN, NDRD was associated with better renal outcomes in patients with type 2 diabetes, as evidenced by a higher cumulative renal survival rate and lower rate of end-stage renal disease (ESRD). Shorter duration of diabetes and absence of retinopathy were independent predictors of NDRD in patients with type 2 diabetes and renal involvement. Renal biopsy is recommended for patients with type 2 diabetes and risk factors for NDRD, to obtain an accurate diagnosis, prompt initiation of disease-specific treatment, and ultimately better renal outcomes with the avoidance of ESRD.
Adult
;
Biopsy
;
Chi-Square Distribution
;
Diabetes Mellitus, Type 2/*complications/diagnosis/therapy
;
Diabetic Nephropathies/diagnosis/etiology
;
Disease Progression
;
Female
;
Glomerulonephritis, IGA/complications/diagnosis
;
Hospitals, University
;
Humans
;
Kaplan-Meier Estimate
;
Kidney Diseases/*complications/diagnosis/therapy
;
Kidney Failure, Chronic/diagnosis/etiology
;
Logistic Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Prognosis
;
Retrospective Studies
;
Risk Factors
;
Time Factors
9.Immunoglobulin A Nephropathy Associated with Plasmodium falciparum Malaria.
Dong Eun YOO ; Jeong Ho KIM ; Jeong Hae KIE ; Yoonseon PARK ; Tae Ik CHANG ; Hyung Jung OH ; Seung Jun KIM ; Tae Hyun YOO ; Kyu Hun CHOI ; Shin Wook KANG ; Seung Hyeok HAN
Journal of Korean Medical Science 2012;27(4):446-449
Glomerulonephritis occurs as a rare form of renal manifestation in Plasmodium falciparum malaria. Herein, we report a case of falciparum malaria-associated IgA nephropathy for the first time. A 49-yr old male who had been to East Africa was diagnosed with Plasmodium falciparum malaria. Microhematuria and proteinuria along with acute kidney injury developed during the course of the disease. Kidney biopsy showed mesangial proliferation and IgA deposits with tubulointerstitial inflammation. Laboratory tests after recovery from malaria showed disappearance of urinary abnormalities and normalization of kidney function. Our findings suggest that malaria infection might be associated with IgA nephropathy.
Acute Kidney Injury/etiology/pathology
;
Antimalarials/therapeutic use
;
Creatinine/blood
;
Glomerulonephritis, IGA/*diagnosis/*etiology
;
Hematuria/etiology
;
Humans
;
Immunoglobulin A/*metabolism
;
Malaria/*complications/drug therapy/*pathology
;
Male
;
Middle Aged
;
Plasmodium falciparum/*isolation & purification
;
Proteinuria/etiology
;
Quinine/therapeutic use
10.Advances in molecular genetics research of IgA nephropathy.
Xiejia LI ; Li XIAO ; Lin SUN ; Fuyou LIU
Journal of Central South University(Medical Sciences) 2011;36(11):1120-1124
Immunoglobulin A nephropathy (IgAN), which can develop into end-stage renal disease, is the most common primary glomerulonephritis. The pathogenesis of IgAN is not clear. Many studies have confirmed that genetic susceptibility is associated with IgAN, and it belongs to polygenic disease. Some studies have found that IgAN is associated with chromosome 6q22-23, 2q36 by linkage analysis, and several candidate genes have been confirmed to be associated with IgAN, such as angiotensin converting enzyme, Fc fragment of IgA receptor, human leukocyte antigen. In recent years, as the progression of molecular genetics and the Human Genome Project, more attention has been paid to the role of genetic factors in the pathogenesis of IgAN.
Animals
;
Chromosomes, Human, Pair 2
;
genetics
;
Chromosomes, Human, Pair 6
;
genetics
;
Genetic Association Studies
;
Genetic Linkage
;
Genetic Predisposition to Disease
;
genetics
;
Glomerulonephritis
;
complications
;
Glomerulonephritis, IGA
;
etiology
;
genetics
;
Humans

Result Analysis
Print
Save
E-mail